A peer-reviewed, open-access journal for research on the science and practice of transfusion medicine, from the blood donor and the laboratory to the patient.
Aims and Scope
IJBT publishes clinical, laboratory, operational and policy research on every step a blood component takes. Topics include, among others:
Recruitment, eligibility, donor health and donor diversity.
Collection, processing, pathogen reduction and storage of red cells, platelets and plasma.
Blood group serology and genotyping, antibody identification and compatibility testing.
Inventory, quality management, accreditation and access to safe blood.
Patient blood management, massive transfusion and neonatal and pediatric practice.
Transfusion reactions, transfusion-transmitted infections and patient outcomes.
Apheresis and cellular therapy, and hematologic conditions managed with transfusion, are also within scope. Read the full Aims and Scope
Published research
All articles are free to read and download under a CC BY 4.0 license, each with a Crossref DOI.
Lucas Bami Agwe, Emmanuel Bah Afuh Bua, Wilfred Chick Abanda, Didimus Sefela Wirba, Mbacham Harry Fon
Mohammad Kaboli, Hadi Bazzazi, Mohammad Taher Hojjati, Shabnam Tabasi, Khodaberdi Kalavi, Fatemeh Mohammadi, Seyed Mojtaba Hoseiniharouni, Omolbanin Majidian, Fresteh Qazzaq
Lorraine N. Lubin, Tiffany Williams, Sophia P. Poorsattar, Ravi C. Gadasally, Jonathan K. Ho, Tristan R. Grogan, Reed Harvey, Jure Marijic, Jacques D. Neelankavil
Ahmed M. Gaji, Ann Ogbenna, Ahmed I. Girei, Kasim M. Pindiga, Sani Adamu, Saleh Yuguda, Ademola Adewoyin, Nosimot Omotola Davies
Editorial Board
Board members handle manuscripts in their fields and advise on scope and policy. View the full Editorial Board
Catherine Reuben
Muhimbili University of Health and Allied Sciences.
Li-Pin Kao
Postdoctoral Research Associate, Center for Cancer Research, Purdue University, U.S.A.
Qinqin Xu
LSU health Shreveport, Shreveport, Louisiana.
Shiwei Duan
Professor, Zhejiang University City College, Hangzhou, Zhejiang
Venkatesh Ponemone
Executive Director, Clinical Development & Operations TotipotentRX Cell Therapy Pvt. Ltd. Manipal University Gurgaon, Haryana, India.
Young-Kyun Lee
Seoul National University Bundang Hospital, Seongnam
Publishing terms
The policies authors, reviewers and librarians look for, in one place.
Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Articles are free to read on publication under the Creative Commons Attribution 4.0 (CC BY 4.0) license. Authors retain copyright.
The APC is USD 1,200, payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy. Fee-relief inquiries are considered case by case; contact the editorial office before or at submission.
IJBT follows COPE guidance. Human research reports ethics approval and informed consent, or a waiver documented by the ethics committee, where applicable. See the Editorial Policies.
Every article receives a Crossref DOI. IJBT articles will be deposited in Portico for long-term preservation.
Published by Open Access Pub. Editorial office: info@openaccesspub.org
Submit
Please read the Instructions for Authors first, then choose one route.
Submit and follow your manuscript through review.
A single form with IJBT already selected.
Questions about scope or files before you submit.
Authors must use only one submission route for the same manuscript.